These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 26181026)
1. Urinary Biomarkers for the Detection and Management of Localized Renal Cell Carcinoma. Rini BI; Campbell SC JAMA Oncol; 2015 May; 1(2):212-3. PubMed ID: 26181026 [No Abstract] [Full Text] [Related]
2. Screening for kidney cancer: is there a role for aquaporin-1 and adipophilin? Grebe SK; Erickson LA Mayo Clin Proc; 2010 May; 85(5):410-2. PubMed ID: 20435833 [No Abstract] [Full Text] [Related]
3. Evaluation of Urine Aquaporin-1 and Perilipin-2 Concentrations as Biomarkers to Screen for Renal Cell Carcinoma: A Prospective Cohort Study. Morrissey JJ; Mellnick VM; Luo J; Siegel MJ; Figenshau RS; Bhayani S; Kharasch ED JAMA Oncol; 2015 May; 1(2):204-12. PubMed ID: 26181025 [TBL] [Abstract][Full Text] [Related]
4. Urinary concentrations of aquaporin-1 and perilipin-2 in patients with renal cell carcinoma correlate with tumor size and stage but not grade. Morrissey JJ; Mobley J; Song J; Vetter J; Luo J; Bhayani S; Figenshau RS; Kharasch ED Urology; 2014 Jan; 83(1):256.e9-14. PubMed ID: 24239027 [TBL] [Abstract][Full Text] [Related]
5. Urine aquaporin 1 and perilipin 2 differentiate renal carcinomas from other imaged renal masses and bladder and prostate cancer. Morrissey JJ; Mobley J; Figenshau RS; Vetter J; Bhayani S; Kharasch ED Mayo Clin Proc; 2015 Jan; 90(1):35-42. PubMed ID: 25572193 [TBL] [Abstract][Full Text] [Related]
6. Urinary KIM-1 and AQP-1 in patients with clear renal cell carcinoma: Potential noninvasive biomarkers. Mijugković M; Stanojević I; Milović N; Cerović S; Petrović D; Jovanović D; Aleksić P; Kovacević B; Andjelić T; Terzic B; Djukić M; Vojvodić D Vojnosanit Pregl; 2016 Mar; 73(3):266-72. PubMed ID: 27295912 [TBL] [Abstract][Full Text] [Related]
7. The specificity of urinary aquaporin 1 and perilipin 2 to screen for renal cell carcinoma. Morrissey JJ; Kharasch ED J Urol; 2013 May; 189(5):1913-20. PubMed ID: 23154208 [TBL] [Abstract][Full Text] [Related]
8. Urinary aquaporin 1 and perilipin 2: Can these novel markers accurately characterize small renal masses and help guide patient management? Song JB; Morrissey JJ; Mobley JM; Figenshau KG; Vetter JM; Bhayani SB; Kharasch ED; Figenshau RS Int J Urol; 2019 Feb; 26(2):260-265. PubMed ID: 30467901 [TBL] [Abstract][Full Text] [Related]
9. Urinary biomarkers for the early diagnosis of kidney cancer. Morrissey JJ; London AN; Luo J; Kharasch ED Mayo Clin Proc; 2010 May; 85(5):413-21. PubMed ID: 20375178 [TBL] [Abstract][Full Text] [Related]
10. Aquaporin-1 protein levels elevated in fresh urine of renal cell carcinoma patients: potential use for screening and classification of incidental renal lesions. Sreedharan S; Petros JA; Master VA; Ogan K; Pattaras JG; Roberts DL; Lian F; Arnold RS Dis Markers; 2014; 2014():135649. PubMed ID: 24803718 [TBL] [Abstract][Full Text] [Related]
11. [A tumor marker for renal cell carcinoma: evaluation of urinary S100-alpha protein]. Tanaka J; Takashi M; Mitsuya H; Haimoto H; Kato K Nihon Hinyokika Gakkai Zasshi; 1987 Dec; 78(12):2051-9. PubMed ID: 3451978 [No Abstract] [Full Text] [Related]
12. Serum and urine biomarkers for human renal cell carcinoma. Pastore AL; Palleschi G; Silvestri L; Moschese D; Ricci S; Petrozza V; Carbone A; Di Carlo A Dis Markers; 2015; 2015():251403. PubMed ID: 25922552 [TBL] [Abstract][Full Text] [Related]
13. GC-MS metabolomics-based approach for the identification of a potential VOC-biomarker panel in the urine of renal cell carcinoma patients. Monteiro M; Moreira N; Pinto J; Pires-Luís AS; Henrique R; Jerónimo C; Bastos ML; Gil AM; Carvalho M; Guedes de Pinho P J Cell Mol Med; 2017 Sep; 21(9):2092-2105. PubMed ID: 28378454 [TBL] [Abstract][Full Text] [Related]
14. Urinary Human Kidney Injury Molecule1- (hKIM1-) is not Increased in Patients with Renal Cell Carcinoma. Bialek L; Poletajew S; Niemczyk M; Czerwinska K; Nowak M; Sadowska A; Borkowski T; Radziszewski P; Dobruch J; Kryst P Urol J; 2020 Oct; 17(6):664-666. PubMed ID: 33000456 [TBL] [Abstract][Full Text] [Related]
15. Urinary microRNAs: Looking for a New Tool in Diagnosis, Prognosis, and Monitoring of Renal Cancer. Oto J; Plana E; Sánchez-González JV; García-Olaverri J; Fernández-Pardo Á; España F; Martínez-Sarmiento M; Vera-Donoso CD; Navarro S; Medina P Curr Urol Rep; 2020 Mar; 21(2):11. PubMed ID: 32166474 [TBL] [Abstract][Full Text] [Related]
16. Urinary RKIP/p-RKIP is a potential diagnostic and prognostic marker of clear cell renal cell carcinoma. Papale M; Vocino G; Lucarelli G; Rutigliano M; Gigante M; Rocchetti MT; Pesce F; Sanguedolce F; Bufo P; Battaglia M; Stallone G; Grandaliano G; Carrieri G; Gesualdo L; Ranieri E Oncotarget; 2017 Jun; 8(25):40412-40424. PubMed ID: 28418894 [TBL] [Abstract][Full Text] [Related]
17. Immunoreactive low-molecular-weight epidermal growth factor in urine of patients with renal cell carcinoma. le Coutre P; Bock S; Jakse G; Petrides PE Urol Res; 1992; 20(4):293-6. PubMed ID: 1509636 [TBL] [Abstract][Full Text] [Related]
18. Nephrocalcin in patients with renal cell carcinoma. Nakagawa Y; Netzer M; Michaels EK; Suzuki F; Ito H J Urol; 1994 Jul; 152(1):29-34. PubMed ID: 8201680 [TBL] [Abstract][Full Text] [Related]
19. Beta-2-glycoprotein-1 and alpha-1-antitrypsin as urinary markers of renal cancer in von Hippel-Lindau patients. Mandili G; Notarpietro A; Khadjavi A; Allasia M; Battaglia A; Lucatello B; Frea B; Turrini F; Novelli F; Giribaldi G; Destefanis P Biomarkers; 2018 Mar; 23(2):123-130. PubMed ID: 28004973 [TBL] [Abstract][Full Text] [Related]
20. Detection of urinary cell-free miR-210 as a potential tool of liquid biopsy for clear cell renal cell carcinoma. Li G; Zhao A; Péoch M; Cottier M; Mottet N Urol Oncol; 2017 May; 35(5):294-299. PubMed ID: 28089386 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]